174 related articles for article (PubMed ID: 19880918)
1. Antipsychotic long-acting injections in clinical practice: medication management and patient choice.
Gray R; Spilling R; Burgess D; Newey T
Br J Psychiatry Suppl; 2009 Nov; 52():S51-6. PubMed ID: 19880918
[TBL] [Abstract][Full Text] [Related]
2. Clinical guideline recommendations for antipsychotic long-acting injections.
Kane JM; Garcia-Ribera C
Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
[TBL] [Abstract][Full Text] [Related]
3. Knowledge about antipsychotic long-acting injections: bridging that gap.
Burns T
Br J Psychiatry Suppl; 2009 Nov; 52():S5-6. PubMed ID: 19880917
[TBL] [Abstract][Full Text] [Related]
4. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
5. Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review.
Taylor D
Br J Psychiatry Suppl; 2009 Nov; 52():S13-9. PubMed ID: 19880912
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
[TBL] [Abstract][Full Text] [Related]
8. Community treatment orders and antipsychotic long-acting injections.
Lambert TJ; Singh BS; Patel MX
Br J Psychiatry Suppl; 2009 Nov; 52():S57-62. PubMed ID: 19880919
[TBL] [Abstract][Full Text] [Related]
9. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
10. Historical perspective on antipsychotic long-acting injections.
Johnson DA
Br J Psychiatry Suppl; 2009 Nov; 52():S7-12. PubMed ID: 19880921
[TBL] [Abstract][Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
12. [Compliance of long-acting atypical antipsychotics: from an image problem to a question of indication].
Naudin J; Dassa D; Cermolacce M
Encephale; 2009 Sep; 35(4):315-20. PubMed ID: 19748367
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.
Waddell L; Taylor M
Br J Psychiatry Suppl; 2009 Nov; 52():S43-50. PubMed ID: 19880916
[TBL] [Abstract][Full Text] [Related]
14. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?
Correll CU; Lauriello J
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505193
[TBL] [Abstract][Full Text] [Related]
15. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication.
Gray R; Rofail D; Allen J; Newey T
J Adv Nurs; 2005 Oct; 52(1):31-7. PubMed ID: 16149978
[TBL] [Abstract][Full Text] [Related]
16. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
Keith S
Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
[TBL] [Abstract][Full Text] [Related]
17. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic long-acting injections: mind the gap.
Patel MX; Taylor M; David AS
Br J Psychiatry Suppl; 2009 Nov; 52():S1-4. PubMed ID: 19880911
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic depot medication and attitudes of community psychiatric nurses.
Patel MX; DE Zoysa N; Baker D; David AS
J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):237-44. PubMed ID: 15788043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
